TBC1D2 Antibodies

Santa Cruz Biotechnology features a diverse variety of TBC1D2 monoclonal antibodies for research in understanding TBC1D2's role in cellular processes. TBC1D2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TBC1D2 belongs to the TBC (Tre-2/Bub2/CDC16) domain family and plays a significant role in regulating intracellular trafficking and signaling pathways. TBC1D2 actively participates in modulating glucose transport within cells. Research focusing on TBC1D2 has revealed its importance in metabolic disorders, particularly in diabetes and obesity studies. Scientists investigating TBC1D2 can gain valuable insights into cellular regulation mechanisms and potential therapeutic approaches. Understanding TBC1D2's functions continues to advance knowledge in metabolism and cellular transport. Exploring TBC1D2's role in health and disease has opened new avenues for therapeutic development. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of TBC1D2's cellular functions and potential therapeutic applications.